International Congress on Oncology Research and Development (iCORD)

The International Congress on Oncology Research and Development (iCORD), will be held at Taj Palace, New Delhi, from October 05-06, 2019.

iCORD is an initiative to bring all stakeholders involved in cancer research and patient care to a common platform discuss and advocate the latest developments in oncology research, drugs/diagnostics, technology, therapies, and patient care programs. It’s an international annual event with aims to promote best in the class, high standard of care in line with global healthcare standards to cancer patients in India.

There are 30 invited speakers in congress from India and abroad. The congress speakers include research experts from Industry, Patient Advocacy Groups and Practicing Oncologist across specialties from India and abroad. The conference agenda can be downloaded from
https://goicord.com/agenda/.

Conference registrations are open and delegates can enjoy early birds rates until July 15, 2019.

The congress will be attended by KOLs across oncology specialties (medical, radiation, surgical, pediatric), Hospitals, Academia, Industry professionals (pharmaceutical, medical biotechnology , medical device, medical imaging solution providers, CROs, SMOs, KPOs, clinical trial supplies storage and logistics providers, market research companies, molecular and central labs, diagnostic and radiological service providers, translation service providers, clinical trials and oncology research software/services providers), medical graduates, and patient advocacy and support groups. Its an excellent platform for clinical research companies to meet the KOLs involved in global oncology clinical trials and to discuss the feasibility of upcoming clinical trials.

The congress also feature an exhibition showcasing the new biotech companies with clinical trials pipelines, clinical research centers/CROs/SMOs/central labs/image reading centers, electronic/software solutions providers engaged in oncology clinical trials, pharma/medical device companies, medical technology service providers, diagnostic imaging agents and radiopharmaceuticals companies with oncology portfolios and wellness solutions/products providers among other exhibitors.

iCORD vision is to translate all oncology research towards cancer patient care. The involvement and support of all stakeholders engaged in cancer patients treatment, support, product/services, research, and advocacy are welcome to support this initiative. For more details on the iCORD, please visit www.goicord.com.

Theme: Translating Research to Better Patient Care

Target Audience:
Oncologists(medical, surgical, radiological, pediatric etc), Industry (medical biotechnology, pharmaceutical, medical device and imaging companies), Cancer diagnostic and Radiological service providers including Central labs and Reading centers, CROs, Hospitals, NGOs, Academia and healthcare insurance providers.

Description:
• An initiative to bring all stakeholders involved in cancer research and patient care to a common platform discuss and advocate the latest developments in oncology research, drugs/diagnostics, technology, therapies and patient care programs.
• Speakers includes research experts from Industry, Patient Advocacy Groups and Practicing Oncologist across specialties from India and abroad.
• Aim to promote cancer patients in India getting the high standard of care in parallel to global healthcare standards.
• Global annual event.

Topics:
This years agenda will be focused to deliberate advancements in cancer immunotherapy research and
diagnostics covering discussion on chimeric antigen receptor (CAR) T-cell immunotherapies to circulating
tumor cells testing. Agenda will also cover sessions on radiation therapy, oncology clinical trials, Biosimilars and logistics supply issues. Below are some of the key agenda/panel topics on the roll :
• Beyond immune checkpoint inhibitors – Adoptive T-cell transfer CAR-T Cell), Immuno cytokines and Oncolytic Viruses.
• Proton Versus Photon in Radiation Therapy.
• Circulating tumor cells testing – future is here.
• Patient advocacy groups- role in cancer patient care management.
• Challenges & opportunities for Asian Biotech in development of cancer therapies.
• Initiating and Integrating clinical trials into clinical practice.
• Debate and controversies around immuno-marker testing.
• The era of biomarkers prognostic and predictive marker for immunotherapy and combinative therapy.
• Complexities and challenges of personalized medicine supply chain.